Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
Clinical trial NCT02456857 · COMPLETED
Trial details
- NCT number
- NCT02456857
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-12
- Primary completion
- 2023-05-24
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.